Azole antifungal resistance today: Focus on Aspergillus

Current Infectious Disease Reports

Volumn 13, Issue 6, 2011, Pages 485-491

  Bowyer, Paul ^a   Moore, Caroline B ^a,b   Rautemaa, Riina ^a,b,c   Denning, David W ^a,b   Richardson, Malcolm D ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aspergillus fumigatus; Azole antifungals; Resistance

Indexed keywords

IMIDAZOLE DERIVATIVE; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; AMINO ACID SUBSTITUTION; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BIOFILM; CHRONIC DRUG ADMINISTRATION; CROSS RESISTANCE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FUNGAL GENE; FUNGUS CULTURE; FUNGUS ISOLATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; INFECTION RESISTANCE; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; STEROL 14ALPHA DEMETHYLASE GENE; UPREGULATION;

EID: 81155153709     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0218-4     Document Type: Article

References (33)

1. HPA Advisory Committee for Fungal Infection and Superficial Parasites. Fungal Diseases in the UK - 2006 http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1196942156347
2. DW Warnock EM Johnson MD Richardson, et al. 1983 Modified response to ketoconazole of Candida albicans from a treatment failure Lancet 19 642 3 10.1016/S0140-6736(83)91809-3 (Pubitemid 13152353)
3. P Fan-Havard D Capano SM Smith, et al. 1991 Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy Antimicrob Agents Chemother 35 2302 5 1804002 1:CAS:528:DyaK38XjslyhsQ%3D%3D
4. JH Rex MG Rinaldi MA Pfaller 1995 Resistance of Candida species to fluconazole Antimicrob Agents Chemother 39 1 8 7695288 1:CAS:528: DyaK2MXislKksr8%3D
5. AE Heald GM Cox WA Schell, et al. 1996 Oropharyngeal yeast flora and fluconazole resistance in HIV infected patients receiving long-term continuous versus intermittent fluconazole therapy AIDS 10 263 8 8882665 10.1097/00002030-199603000-00004 1:CAS:528:DyaK28Xitl2htL0%3D (Pubitemid 26093485)
6. R Rautemaa M Richardson M Pfaller, et al. 2007 Decreased sensitivity of Candida albicans to azole antifungals-a complication of long term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients J Antimicrob Chemother 60 889 92 17704513 10.1093/jac/dkm299 1:CAS:528:DC%2BD2sXht1ygtbnE (Pubitemid 47434273)
7. E Siikala R Rautemaa M Richardson, et al. 2010 Persistent Candida albicans colonization and molecular mechanisms of azole resistance in APECED J Antimicrob Chemother 65 2505 13 20876623 10.1093/jac/dkq354 1:CAS:528: DC%2BC3cXhsVektrfJ
8. VE Mulanovich DP Kontoyiannis 2011 Fungal pneumonia in patients with hematologic malignancies: current approach and management Curr Opin Infect Dis 24 323 32 21666457 10.1097/QCO.0b013e3283486d1d
9. PE Verweij E Snelders GH Kema, et al. 2009 Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 9 789 95 19926038 10.1016/S1473-3099(09)70265-8 1:CAS:528: DC%2BC3cXhtFyisbfF A comprehensive review on all aspects of azole resistance in Aspergillus fumigatus
10. th Edition. Wiley-Blackwell, Chichester, 2012 (in press).
11. NL Smith DW Denning 2011 Underlying conditions in chronic aspergillosis including simple aspergilloma Eur Respir J 37 865 72 20595150 10.1183/09031936.00054810 1:STN:280:DC%2BC3MzotFymsQ%3D%3D
12. AC Pasqualotto G Powell R Niven, et al. 2009 The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis Respirology 14 1121 27 19909460 10.1111/j.1440-1843.2009.01640.x
13. DW Denning BR O'Driscoll CM Hogaboam, et al. 2006 The link between fungi and asthma-a summary of the evidence Eur Respir J 27 615 26 16507864 10.1183/09031936.06.00074705 1:STN:280:DC%2BD287itVKrsA%3D%3D (Pubitemid 43372538)
14. DW Denning 1997 Itraconazole resistance in Aspergillus fumigatus Antimicrob Agents Chemother 41 1364 8 9174200 1:CAS:528:DyaK2sXjsFCltb8%3D The first report of azole resistance in Aspergillus fumigatus (Pubitemid 27231443)
15. SJ Howard D Cerar MJ Anderson, et al. 2009 Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure Emerg Infect Dis 15 1068 76 19624922 10.3201/eid1507.090043 1:CAS:528: DC%2BD1MXptFGhs7w%3D The first report of azole in Aspergillus fumigatus in the UK
16. E Dannaoui E Borel F Persat, et al. 1999 In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus J Med Microbiol 48 1087 93 10591162 10.1099/00222615-48-12-1087 1:CAS:528: DC%2BD3cXhs1Sktg%3D%3D
17. PE Verweij DT Te Dorsthorst AJ Rijs, et al. 2002 Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998 J Clin Microbiol 40 2648 50 12089298 10.1128/JCM.40.7.2648-2650.2002 1:CAS:528:DC%2BD38XlvVSru7k%3D (Pubitemid 34747381)
18. EK Manavathu OC Abraham PH Chandrasekar 2001 Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus Clin Microbiol Infect 7 130 7 11318811 10.1046/j.1469-0691.2001.00220.x 1:CAS:528:DC%2BD3MXktFKitLs%3D (Pubitemid 34960290)
19. J Mosquera A Sharp CB Moore, et al. 2002 In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp J Antimicrob Chemother 50 189 94 12161398 10.1093/jac/dkf111 1:CAS:528:DC%2BD38Xms1Kmu70%3D (Pubitemid 34918847)
20. A Warris CM Weemaes PE Verweij 2002 Multidrug resistance in Aspergillus fumigatus N Engl J Med 347 2173 4 12501236 10.1056/NEJM200212263472618 The first report of the emergence of multidrug resistance against azole antifungals. An illustrative case report demonstrated that long-term prophylaxis with itraconazole resulted in infection with A. fumigatus strains that were resistant to azoles
21. KL Oakley G Morrissey DW Denning 1997 Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus Antimicrob Agents Chemother 41 1504 7 9210674 1:CAS:528: DyaK2sXktlyrurg%3D (Pubitemid 27289676)
22. N Osherov DP Kontoyiannis A Romans, et al. 2001 Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA J Antimicrob Chemother 48 75 81 11418514 10.1093/jac/48.1.75 1:CAS:528: DC%2BD3MXlsVegtbw%3D (Pubitemid 32684728)
23. JW Slaven MJ Anderson D Sanglard, et al. 2002 Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate Fungal Genet Biol 36 199 206 12135575 10.1016/S1087-1845(02)00016-6 1:CAS:528:DC%2BD38XlsFKhs7w%3D
24. AM Nascimento GH Goldman S Park, et al. 2003 Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole Antimicrob Agents Chemother 47 1719 26 12709346 10.1128/AAC.47.5.1719-1726.2003 1:CAS:528:DC%2BD3sXjslGhur0%3D (Pubitemid 36548560)
25. E Snelders WJ Melchers PE Verweij 2011 Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? Future Microbiol 6 335 47 21449843 10.2217/fmb.11.4 1:CAS:528:DC%2BC3MXktVCmtrk%3D A timely, comprehensive review of azole resistance in Aspergillus fumigatus and the implications for treating patients with invasive aspergillosis
26. A Bueid SJ Howard CB Moore, et al. 2010 Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009 J Antimicrob Chemother 65 2116 8 20729241 10.1093/jac/dkq279 1:CAS:528:DC%2BC3cXhtFylsb3J This report updates the level of azole resistance in Aspergillus fumigatus seen in isolates from patients attending the National Aspergillosis Centre, UK
27. DW Denning S Park C Lass-Florl, et al. 2011 High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease Clin Infect Dis 52 1123 9 21467016 10.1093/cid/cir179 1:CAS:528:DC%2BC3MXksFGktbw%3D This study describes the direct detection of resistance in culture-negative clinical samples using rapid molecular methods to detect resistance markers. Using this approach a high rate of azole resistance (55.1%)
28. G Ramage E Mowat B Jones, et al. 2009 Our current understanding of fungal biofilms Crit Revs Microbiol 35 340 55 10.3109/10408410903241436 1:CAS:528:DC%2BD1MXhtleku7%2FM
29. F-M Müller M Seidler A Beauvais 2011 Aspergillus biofilms in the clinical setting Med Mycol 49 Suppl 1 S96 S100 21254964 10.3109/13693786.2010. 502190
30. Ferreira da Silva JL Capellaro E dos Reis Marques, et al. 2004 In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance Antimicrob Agents Chemother 48 4405 13 10.1128/AAC.48.11.4405-4413.2004 (Pubitemid 39434904)
31. R Rajendran E Mowat E McCulloch, et al. 2011 Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity Antimicrob Agents Chemother 55 2092 97 21321135 10.1128/AAC.01189-10
32. Howard SJ, Harrison E, Bowyer P, et al.: Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011. [Epub ahead of print].
33. KL Mortensen RH Jensen HK Johansen, et al. 2011 Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance J Clin Microbiol 49 2243 51 21508152 10.1128/JCM.00213-11